Apeiron Investment Group overview
Apeiron Investment Group contact information
Offices
66-67 Amery Street, Sliema, SLM1707, MaltaContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Christian Angermayer | Job titleCo-Founder and General Partner | LocationSliema, Malta | Email  ----- |
| Key ContactMr. Fabian Hansen | Job titleCo-Founder and General Partner | LocationWest Hollywood, United States | Email -------- |
| Key ContactMr. Nick Nigam | Job titleChief Investment Officer | LocationBerlin, Germany | Email ------ |
| Mr. Marc Weber | Job titleChief Financial Officer | LocationLondon, United Kingdom | Email -------- |
Apeiron Investment Group fund commitments
Known fund commitments: 1
| Fund | Manager | Commitment date | Commitment size |
|---|---|---|---|
Manager ---------- | Commitment dateMar 2021 | Commitment size- | |
Apeiron Investment Group funds managed
Closed funds: 2
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ----------- | Close dateJan 2022 | Strategy ------ | |
Fund size ------ | Close dateJul 2019 | Strategy ----- | |
Stories that mention Apeiron Investment Group
Bullish to go public via merger with Far Peak SPAC
Bullish, a developer of financial services for the digital assets sector, has agreed to go public via a merger with with Far Peak Acquisition Corporation, a blank check company whose backers include BlackRock.
Cambrian Biopharma attracts $60m
Cambrian Biopharma, a distributed drug discovery company, has raised $60 million in funding.
Animal fat producing startup Hoxton Farms nabs seed funding
London-based Hoxton Farms, an animal fat producing startup, has raised 2.7 million pounds in seed funding.
VC-backed Sensei Biotherapeutics raises $133m for IPO
Sensei Biotherapeutics, a developer of next-generation cancer treatments, has raised about $133 million for its IPO after pricing its over 7 million shares at $10 per share.
VC-backed Sensei Biotherapeutics sets IPO pricing terms
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, has priced its over 5.8 million shares between $16 and $18 per share.
ATAI Life Sciences takes in $24m
ATAI Life Sciences, a biotech company focused on ending mental illnesses, has raised $24 million in convertible note financing.
Deposit Solutions raises $100 mln
Deposit Solutions, of Hamburg, has raised $100 million in a round led by Vitruvian Partners. Kinnevik also invested as well as existing shareholders including e.ventures. The round valued Deposit Solutions, which provides a platform for savings deposits, at $500 million.
Juvenescence hauls in $12.3 mln seed
Juvenescence, a developer of therapies for ageing and age-related diseases, has raised $12.3 million in seed funding round. The investors included Foresite Capital and Apeiron Investment Group.